Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Cardiovascular risk profile and risk stratification of the hypertensive population attended by general practitioners and specialists in Spain. The CONTROLRISK study

Abstract

The CONTROLRISK study was designed to determine the cardiovascular risk profile of the hypertensive population attended at primary care and specialist setting in Spain and to investigate whether physicians stratify the risk correctly, according to the 2003 European guidelines. A total of 8920 patients were recruited from primary care (n=4485) and specialist outpatient clinic (n=4435). The age criteria was 62.6±11.1 years; 51.6% were women. No differences were observed in the severity of hypertension. More than 85% presented other cardiovascular risk factors, similarly in both groups. Target organ damage (TOD) and associated clinical conditions (ACC) were more frequent in specialist setting (57.6 vs 34.3% and 39 vs 28.7%, both P<0.0001). The most common risk factor was age. The most frequently reported TOD was left ventricular hypertrophy (42.3 and 22.1%; P<0.0001). Ischemic heart disease was the most common ACC (21.5 vs 13.1%; P<0.0001). The risk profile was significantly higher in specialist population (75.1 vs 60.3% of patients belonged to high- or very high-risk groups). Specialists and primary care physicians stratified only 54.6 and 48% of their patients correctly, respectively (P<0.05). Both, specialists and general practitioners (GPs) strongly underestimated the risk. Very high-risk patients were adequately assessed only in 44.9% of cases by specialists and in 25.3% by GPs (P<0.001). More than half of the hypertensive patients attended by GPs in Spain belong to the high- or very high-risk groups. GPs and specialists tend to underestimate the cardiovascular risk in daily clinical practice, mainly in very high-risk patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Primatesta P, Poulter NR . Hypertension management and control among English adults aged 65 years and older in 2000 and 2001. J Hypertens 2004; 22: 1093–1098.

    Article  CAS  PubMed  Google Scholar 

  2. Primatesta P, Poulter NR . Improvement in hypertension management in England: results from the Health Survey for England 2003. J Hypertens 2006; 24: 1187–1192.

    Article  CAS  PubMed  Google Scholar 

  3. Fagard RH, Van Den Enden M, Leeman M, Warling X . Survey on treatment of hypertension and implementation of World Health Organization/International Society of Hypertension risk stratification in primary care in Belgium. J Hypertens 2002; 20: 1297–1302.

    Article  CAS  PubMed  Google Scholar 

  4. Hajjar I, Kotchen TA . Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA 2003; 290: 199–206.

    Article  PubMed  Google Scholar 

  5. Rodriguez GC, Artigao LM, Llisterri JL, Alonso FJ, Banegas JR, Lou S et al. Control of hypertension in elderly patients receiving primary care in Spain. Rev Esp Cardiol 2005; 58: 359–366.

    Article  Google Scholar 

  6. Banegas JR, Rodriguez-Artalejo F, Ruilope LM, Graciani A, Luque M, De la Cruz-Troca JJ et al. Hypertension magnitude and management in the elderly population of Spain. J Hypertens 2002; 20: 2157–2164.

    Article  CAS  PubMed  Google Scholar 

  7. Roca B, Suarez C, Ceballos A, Varela JM, Nonell F, Montes J et al. Control of hypertension in patients at high risk of cardiovascular disease. QJM 2005; 98: 581–588.

    Article  CAS  PubMed  Google Scholar 

  8. Aranda P . Arterial hypertension in Spain: the experience of the Spanish League. J Hum Hypertens 1996; 10 (Suppl 1): S73–S75.

    PubMed  Google Scholar 

  9. Puras A, Sanchis C, Artigao LM, Divison JA . Prevalence, awareness, treatment, and control of hipertension in a Spanish population. Eur J Epidemiol 1998; 14: 31–36.

    Article  CAS  PubMed  Google Scholar 

  10. Banegas JR, Segura J, Ruilope LM, Luque M, Garcia-Robles R, Campo C et al. Blood pressure control and physician management of hypertension in hospital hypertension units in Spain. Hypertension 2004; 43: 1338–1344.

    Article  CAS  PubMed  Google Scholar 

  11. The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and the National High Blood Pressure Education Program Coordinating Committee. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413–2446.

    Article  Google Scholar 

  12. Whitworth JA, 2003 World Health Organization (WHO)/International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21: 1983–1992.

    Article  PubMed  Google Scholar 

  13. 2003 European Society of Hypertension. European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011–1053.

    Article  Google Scholar 

  14. Gonzalez JR, Alegria E, Aznar J, Bertomeu V, Franch J, Palma JL . Knowledge and implementation of cardiovascular risk clinical practice guidelines by general practitioners and specialists. Rev Esp Cardiol 2006; 59: 801–806.

    Article  Google Scholar 

  15. Spranger CB, Ries AJ, Berge CA, Radford NB, Victor RG . Identifying gaps between guidelines and clinical practice in the evaluation and treatment of patients with hypertension. Am J Med 2004; 117: 14–18.

    Article  PubMed  Google Scholar 

  16. Backlund L, Bring J, Strender L-E . How accurately do general practitioners and students estimate coronary risk in hypercholesterolaemic patients. Primary Health Care Res Dev 2004; 5: 145–152.

    Article  Google Scholar 

  17. Persson M, Carlberg B, Mjörndal T, Asplund K, Bohlin J, Lindholm L . 1999 WHO/ISH guidelines applied to a 1999 MONICA sample from northern Sweden. J Hypertens 2002; 20: 29–35.

    Article  CAS  PubMed  Google Scholar 

  18. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL . International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006; 295: 180–189.

    Article  CAS  PubMed  Google Scholar 

  19. Rutten FH, Grobbee DE, Hoes AW . Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice. Eur J Heart Fail 2003; 5: 337–344.

    Article  PubMed  Google Scholar 

  20. Peters TJ, Montgomery AA, Fahey T . How accurately do primary health care professionals use cardiovascular risk tables in the management of hypertension? Br J Gen Pract 1999; 49: 987–988.

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Montgomery AA, Fahey T, Mackintosh C, Sharp DJ, Peters TJ . Estimation of cardiovascular risk in hypertensive patients in primary care. Br J Gen Pract 2000; 50: 127–128.

    CAS  PubMed  PubMed Central  Google Scholar 

  22. McManus RJ, Mant J, Meulendijks CFM, Salter RA, Pattison HM, Roalfe AK et al. Comparison of estimates calculations risk of coronary heart disease by doctors and nurses using different calculation tools in general practice: cross sectional study. BMJ 2002; 324: 459–464.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Sheridan S, Pignone M, Mulrow C . Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians. J Gen Intern Med 2003; 18: 1060–1061.

    Article  Google Scholar 

  24. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF et al. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 2004; 328: 634–640.

    Article  PubMed Central  PubMed  Google Scholar 

  25. Simpson FO . Guidelines for antihypertensive therapy: problems with a strategy based on absolute cardiovascular risk. J Hypertens 1996; 14: 683–689.

    Article  CAS  PubMed  Google Scholar 

  26. Camisasca P, Avanzini F, Alli C, Colombo F, Tognoni G . Overall cardiovascular risk still ignored in general practice care of hypertension. J Cardiovasc Risk 2002; 9: 147–152.

    Article  PubMed  Google Scholar 

  27. Gonzalez JR, Alegria E, Lozano JV, Caro JL, Acuna JG, Maqueda IG . Impact of hypertension in cardiac diseases in Spain. The CARDIOTENS Study 1999. Rev Esp Cardiol 2001; 54: 139–149.

    Article  Google Scholar 

  28. Cabana M, Rand C, Powe N, Wu A, Wilson M, Abbound PA et al. Why don't physicians follow clinical practice guidelines? JAMA 1999; 282: 1458–1465.

    Article  CAS  PubMed  Google Scholar 

  29. Echlin PS, Upshur RE, Markova TP . Lack of chart reminder effectiveness on family medicine resident JNC-VI and NCEP III guideline knowledge and attitudes. BMC Fam Pract 2004; 5: 14.

    Article  PubMed Central  PubMed  Google Scholar 

  30. Brand C, Landgren F, Hutchinson A, Jones C, Macgregor L, Campbell D . Clinical practice guidelines: barriers to durability after effective early implementation. Intern Med J 2005; 35: 162–169.

    Article  CAS  PubMed  Google Scholar 

  31. Hutchinson BG, Abelson J, Woodward CA, Norman G . Preventive care and barriers to effective prevention: how do family physicians see it. Can Fam Physician 1996; 42: 1693–1700.

    Google Scholar 

  32. Cuspidi C, Meani S, Salerno M, Severgnini B, Fusi V, Valerio C et al. Cardiovascular risk stratification according to the 2003 ESH/ESC guidelines in uncomplicated patients with essential hypertension: comparison with the 1999 WHO/ISH guidelines criteria. Blood Press 2004; 13: 144–151.

    PubMed  Google Scholar 

  33. Luque M, de Rivas B, Alvarez B, Garcia G, Fernandez C, Martell N . Influence of target organ lesion detection (assessment of microalbuminuria and echocardiogram) in cardiovascular risk stratification and treatment of untreated hypertensive patients. J Hum Hypertens 2006; 20: 187–192.

    Article  CAS  PubMed  Google Scholar 

  34. Sever P, Dahlöf B, Poulter N, Wedel H, Beevers G, Caulfield M et al. For the ASCOT INVESTIGATORS prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm (ASCOT–LLA): a multicentre randomised controlled trial. Lancet 2003; 361: 1149–1158.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The present study was supported by an unrestricted grant provided by the HOR Unit of Novartis Pharmaceuticals.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to V Barrios.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barrios, V., Escobar, C., Calderón, A. et al. Cardiovascular risk profile and risk stratification of the hypertensive population attended by general practitioners and specialists in Spain. The CONTROLRISK study. J Hum Hypertens 21, 479–485 (2007). https://doi.org/10.1038/sj.jhh.1002167

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1002167

Keywords

This article is cited by

Search

Quick links